#HeartSuccess Series - Guidelines for the Win: The new standard in HFrEF management

In this episode, Dr. James Januzzi, Hutter Family Professor of Medicine at Harvard Medical School and cardiologist at the Massachusetts General Hospital in Boston, discusses with Dr. Shelley Zieroth, Cardiologist at St. Boniface Hospital in Winnipeg, Manitoba and the Immediate Past President of the Canadian Heart Failure Society. Dr. Zieroth and Dr. Januzzi discuss the 2021 updates to the ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment as well as the 2021 CCS/CHFS Heart Failure Guidelines Update. They discuss emerging evidence that support the treatment of HFrEF with 4 standard therapies: ARNI, Beta Blocker, MRA and SGLT2is. They end their conversation with an important message on the way healthcare professionals can advise their patients on how these comprehensive therapies can help them live longer and improve their quality of life. For more information and resources, visit the Canadian Heart Failure Website at www.heartfailure.ca This program is made possible through funding from Novartis Canada.